198 related articles for article (PubMed ID: 8080049)
1. Pancreatic carcinomas of acinar and mixed acinar/ductal phenotypes in Ela-1-myc transgenic mice do not contain c-K-ras mutations.
Schaeffer BK; Terhune PG; Longnecker DS
Am J Pathol; 1994 Sep; 145(3):696-701. PubMed ID: 8080049
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of c-K-ras in pancreatic carcinomas from Ela-1, SV40E transgenic mice.
Kuhlmann E; Terhune PG; Longnecker DS
Carcinogenesis; 1993 Dec; 14(12):2649-51. PubMed ID: 8269641
[TBL] [Abstract][Full Text] [Related]
3. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
4. Only wild-type c-Ki-ras codons 12, 13, and 61 in human pancreatic acinar cell carcinomas.
Terhune PG; Heffess CS; Longnecker DS
Mol Carcinog; 1994 Jun; 10(2):110-4. PubMed ID: 8031464
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
6. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
[TBL] [Abstract][Full Text] [Related]
7. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.
Pellegata NS; Sessa F; Renault B; Bonato M; Leone BE; Solcia E; Ranzani GN
Cancer Res; 1994 Mar; 54(6):1556-60. PubMed ID: 8137263
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
9. Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation.
Matsubayashi H; Watanabe H; Nishikura K; Ajioka Y; Kijima H; Saito T
Cancer; 1998 Feb; 82(4):651-60. PubMed ID: 9477096
[TBL] [Abstract][Full Text] [Related]
10. Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas.
Chang KW; Laconi S; Mangold KA; Hubchak S; Scarpelli DG
Cancer Res; 1995 Jun; 55(12):2560-8. PubMed ID: 7780969
[TBL] [Abstract][Full Text] [Related]
11. Recent results in animal models of pancreatic carcinoma: histogenesis of tumors.
Longnecker DS; Memoli V; Pettengill OS
Yale J Biol Med; 1992; 65(5):457-64; discussion 465-9. PubMed ID: 1340063
[TBL] [Abstract][Full Text] [Related]
12. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.
Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM
Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455
[TBL] [Abstract][Full Text] [Related]
13. [Differential genetic pathway of duct and acinar carcinomas of the pancreas].
Tsutsumi M
Gan To Kagaku Ryoho; 2005 May; 32(5):593-8. PubMed ID: 15918556
[TBL] [Abstract][Full Text] [Related]
14. K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines.
Erill N; Cuatrecasas M; Sancho FJ; Farré A; Pour PM; Lluís F; Capellá G
Am J Pathol; 1996 Oct; 149(4):1333-9. PubMed ID: 8863680
[TBL] [Abstract][Full Text] [Related]
15. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
16. A novel experimental model for human mixed acinar-ductal pancreatic cancer.
Doiron B; DeFronzo RA
Carcinogenesis; 2018 Feb; 39(2):180-190. PubMed ID: 29106450
[TBL] [Abstract][Full Text] [Related]
17. Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats.
van Kranen HJ; Vermeulen E; Schoren L; Bax J; Woutersen RA; van Iersel P; van Kreijl CF; Scherer E
Carcinogenesis; 1991 Aug; 12(8):1477-82. PubMed ID: 1860169
[TBL] [Abstract][Full Text] [Related]
18. K-ras mutation in focal proliferative lesions of human pancreas.
Terhune PG; Phifer DM; Tosteson TD; Longnecker DS
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):515-21. PubMed ID: 9641496
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of p53 mutation in pancreatic acinar cell carcinomas of humans and transgenic mice.
Terhune PG; Memoli VA; Longnecker DS
Pancreas; 1998 Jan; 16(1):6-12. PubMed ID: 9436856
[TBL] [Abstract][Full Text] [Related]
20. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.
Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA
Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]